Topics:
Breast Cancer • Medical Oncology
Do you routinely add anti-hormonal therapy to HER2 directed therapy in a patient with ER+ HER2+ breast cancer?
For example, if a post-menopausal patient is treated in the first line setting with docetaxel, herceptin, and perjeta, would you add an aromatase inhibitor following completion of chemotherapy?
Answer from: Medical Oncologist at Community Practice
That is my usual practice.As soon as the cytotoxic part of chemo is over,patient would go on AI.
I consider their long term cure and the fact that HER 2 has been countered effectively places even more importance on appropriate Hormonal strategy for cure.
Sign in or Register to read more